SAN FRANCISCO, Jan. 9, 2026 /PRNewswire/ -- Hyperscaler development company Fermi Inc. (NASDAQ: FRMI) is facing a proposed securities class action stemming from its highly anticipated initial public offering completed just weeks before stunning the investment community with its December announcement that the prospective anchor tenant ("First Tenant") for the company's Project Matador (the company's Advanced Energy and Intelligence Campus at Texas Tech University) terminated an agreement that would have advanced $150 million to help fund construction. Hagens Berman is investigating the alleged claims that Fermi IPO materials were misleading and urges investors in Fermi who suffered significant losses to …

SAN DIEGO, Jan. 9, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that investors in SLM Corporation a/k/a Sallie Mae (NASDAQ: SLM; SLMBP) securities between July 25, 2025 and August 14, 2025, inclusive (the "Class Period"), have until February 17, 2026 to seek appointment as lead plaintiff of the SLM class action lawsuit. Captioned Zappia v.

Shares of Netflix have tumbled since October, when the streaming giant became one of the presumed suitors for Warner Bros. Discovery.

NEW YORK, Jan. 9, 2026 /PRNewswire/ -- S&P Global's (NYSE: SPGI) fourth quarter and full-year 2025 results will be issued on Tuesday, February 10, 2026 via news release at approximately 7:15 a.m. Eastern Time.

Bed Bath & Beyond (BBBY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Apogee Enterprises, Inc. (NASDAQ: APOG) or certain of its officers and directors may have violated federal securities laws.

SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces an investigation into potential breaches of fiduciary duty by the Board of Directors of Grindr Inc. (NYSE: GRND).

SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential derivative claims on behalf of Five Below, Inc. (NASDAQ: FIVE) concerning alleged breaches of fiduciary duty and other violations of state and federal law by certain officers and directors.

Control over Venezuela's oil has been in the spotlight all week, but developments in Iran are key to crude's latest rise.

Revolution Medicines (RVMD) remains a "Strong Buy", driven by advanced RAS [ON] inhibitor programs and robust clinical progress, notably with Daraxonrasib. Company's phase 3 RASolute-302 trial in metastatic PDAC RAS-mutant patients is a major catalyst, with data expected in 2026 and significant expansion potential. Buyout interest from major pharma, including rumored $28–32B bids, underscores RVMD's strategic value and enhances upside optionality.

GAP faces Athleta's prolonged reset, but strong comps at Old Navy raise the question of whether portfolio strength can offset the drag.

Electric vehicle stocks haven't fared well ever since the EV tax credit expired on September 30, 2025.

We are entering a new earnings season. Earnings reports are crucial to understanding a company's outlook for revenue and profit in the coming quarters, especially as headwinds still exist in many sectors of the economy.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ARDENT HEALTH, INC. (ARDT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 12, 2025, after market hours, Ardent released its third.

JOBY plans to double aircraft output by 2027 after buying a 700,000-square-foot Dayton facility, expanding Ohio operations and near-term capacity.

Jazz Pharmaceuticals plc (JAZZ) Discusses HERIZON-GEA-01 Phase III Trial Results for Zanidatamab in HER2+ GEA Transcript

CNBC's Julia Boorstin reports on Meta's nuclear deals.

CNBC's "The Exchange" team discusses commodities, including gold and oil, as well as President Trump's meeting with oil companies about Venezuela with Jeffrey Currie of the Carlyle Group.

The Elliott wave indicates the index is in a 3rd wave, with an ideal target of approximately 7250, followed by a 4th-wave pullback to ~7100 and another 5th-wave rally to approximately 7345-7490.

Chrysler parent Stellantis said on Friday it will stop selling plug-in hybrid versions of the Jeep Wrangler and Grand Cherokee, and the Chrysler Pacifica minivan, in the United States as it navigates soft demand and shifts its North American electrification strategy.